I. Rozenberg

发表

A Probabilistic Functional Network of Yeast Genes

G. Sumara, I. Sumara, I. Rozenberg, 2004 .

Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome

I. Rozenberg, F. Gasparini, O. Grenet, 2016, Clinical Epigenetics.

Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo.

I. Rozenberg, M. Kurrer, A. Akhmedov, 2014, European heart journal.

First‐in‐human study demonstrating the safety and clinical efficacy of novel anti‐IL‐17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis

I. Rozenberg, C. Calonder, F. D. Di Padova, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

IL‐17A is a pertinent therapeutic target for moderate‐to‐severe hidradenitis suppurativa: Combined results from a pre‐clinical and phase II proof‐of‐concept study

A. Kimball, I. Rozenberg, F. Kolbinger, 2022, Experimental dermatology.

Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial.

I. Rozenberg, A. Risitano, G. Junge, 2021, The Lancet. Haematology.

Protein synthesis levels are increased in a subset of individuals with fragile X syndrome

I. Rozenberg, F. Gasparini, G. Pedini, 2018, Human molecular genetics.

Restraint stress enhances arterial thrombosis in vivo – role of the sympathetic nervous system

M. Gassmann, I. Rozenberg, T. Lüscher, 2014, Stress.

Requirement of JNK2 for Scavenger Receptor A-Mediated Foam Cell Formation in Atherogenesis

G. Sumara, I. Sumara, I. Rozenberg, 2004, Science.

Histamine H1 Receptor Promotes Atherosclerotic Lesion Formation by Increasing Vascular Permeability for Low-Density Lipoproteins

Burkhard Becher, Alexander Akhmedov, I. Rozenberg, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Deletion of L-Selectin Increases Atherosclerosis Development in ApoE−/− Mice

I. Rozenberg, J. Borén, T. Lüscher, 2011, PloS one.

Effects of Tacrolimus or Sirolimus on Proliferation of Vascular Smooth Muscle and Endothelial Cells

I. Rozenberg, T. Lüscher, C. Matter, 2006, Journal of cardiovascular pharmacology.

Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria

I. Rozenberg, M. Keating, I. Splawski, 2021, Haematologica.

12-Month Analysis of a Phase 2 Study of Iptacopan (LNP023) Monotherapy for Paroxysmal Nocturnal Hemoglobinuria

I. Rozenberg, R. Chawla, B. Ko, 2021, Blood.

Cyclophilin A differentially activates monocytes and endothelial cells: role of purity, activity, and endotoxin contamination in commercial preparations.

I. Rozenberg, T. Lüscher, F. Tanner, 2008, Atherosclerosis.

Histamine H 1 Receptor Promotes Atherosclerotic Lesion Formation by Increasing Vascular Permeability for Low-Density Lipoproteins

I. Rozenberg, A. Akhmedov, B. Becher, 2010 .

Aging Induces Endothelial Dysfunction While Sparing Arterial Thrombosis

I. Rozenberg, A. Akhmedov, T. Lüscher, 2010, Arteriosclerosis, thrombosis, and vascular biology.

A Placebo‐Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa‐Induced Dyskinesia

L. Defebvre, I. Rozenberg, O. Rascol, 2016, Movement Disorders.

Protein synthesis levels are increased in a subset of individuals with fragile X syndrome

I. Rozenberg, F. Gasparini, G. Pedini, 2018, Human molecular genetics.

Inactivity of nitric oxide synthase gene in the atherosclerotic human carotid artery

I. Rozenberg, T. Lüscher, J. Schmidli, 2007, Basic Research in Cardiology.

Aging Induces Endothelial Dysfunction While Sparing Arterial Thrombosis

I. Rozenberg, A. Akhmedov, T. Lüscher, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Restraint stress enhances arterial thrombosis in vivo – role of the sympathetic nervous system

M. Gassmann, I. Rozenberg, T. Lüscher, 2014, Stress.